# WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases

> **NCT06243003** · PHASE1,PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 56 (estimated)

## Conditions studied

- SCLC,Extensive Stage
- Brain Metastases

## Interventions

- **RADIATION:** HA-WBRT plus SBRT

## Key facts

- **NCT ID:** NCT06243003
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-15
- **Primary completion:** 2025-07
- **Final completion:** 2026-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06243003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06243003, "WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06243003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*